Tonje R. Johannessen retweeted
Congratulations to our PhD candidate Ingrid Engebretsen on her fantastic presentation at #ESCCongress2024.
Non-adherence to PCSk9i and oral LLT is a major challenge in Norway
@atferdsmedisin @OsloEconomics @VestreViken @sighalvo @Kristinamalene
Tonje R. Johannessen retweeted
The new #ESC2024 guidelines on #hypertension are finally out. Read and learn how to improve management of HT in #women and #men. @FemaleheartB @ESCardioNews @medofak_uib @haukeland_no
Tonje R. Johannessen retweeted
Check out our just presented Late-breaking science on a machine learning algorithm using POCT and immediately available clinical variables for immediate rule-out of myocardial infarction:
NEW Research: Diagnostic accuracy of a machine learning algorithm using point-of-care high-sensitivity cardiac troponin I for rapid rule-out of myocardial infarction: a retrospective study. #MachineLearning
Read it here: buff.ly/4g5IMwo
Tonje R. Johannessen retweeted
Another great study indicating the clinical utility of high-sensitivity entering the point-of-care troponin test arena. 🚨🚑❤️🩹Congrats to @luca_koechlin, @J_Boeddinghaus, @LopezAyalaP, @mrubini and team!
jacc.org/doi/10.1016/j.jacc.…
Tonje R. Johannessen retweeted
🚨 New data on preloading in suspected NSTE-#ACS — mainly a German issue? Pre-hospital heparin in suspected NSTE-ACS patients may not improve outcomes, raising concerns about widespread use without evidence.🚑 More data urgently needed!
Read more here: link.springer.com/article/10…
Tonje R. Johannessen retweeted
Very glad to share our latest manuscript published in @LancetDigitalH
Fantastic effort from all APACE Investigators @J_Boeddinghaus
@luca_koechlin @thomas_nest @zimmermann_to @PaoloEM91 @OmiroOscar @fjjms @CRIBasel @UniSpitalBasel
thelancet.com/journals/landi…
Tonje R. Johannessen retweeted
New article in European Heart Journal @yadersandoval @louiseacullen @mrapple004
Point-of-care high-sensitivity cardiac troponin in suspected acute myocardial infarction assessed at baseline and 2 h
academic.oup.com/eurheartj/a…
Tonje R. Johannessen retweeted
The #RapidCTCA trial presented by Professor Newby #ICNCCT2024
6 Scottish sites!
No benefit for CTCA in acute intermediate risk chest pain in any subgroups,
likely due in part to the advent of high sensitivity troponin
Tonje R. Johannessen retweeted
We are joining forces from Norway and Denmark to investigate this important research question. It big thanks to our study team and participating centers who soon have randomized 5600 pts!
The Danish-Norwegian randomised trial on β-blockers after myocardial infarction: design and baseline characteristics of the DANBLOCK-BETAMI trial bit.ly/41PJTcP
@AgewallStefan @FeliceGragnano @dan_atar @eva_prescott @john_munkhaugen #EHJPharmacotherapy #ESCYoung #CAD
Tonje R. Johannessen retweeted
#November2023 #OriginalResearch
Prehospital early warning scores for adults with suspected sepsis: retrospective diagnostic cohort study
emj.bmj.com/content/40/11/76…
@K_Ifti @DrSusieC @Dr_J_M_Dickson
Tonje R. Johannessen retweeted
My last session at #ESCCongress2023 with some members of the task force for ESC ACS 2023 Guidelines based on clinical cases
⭐️I was honoured to be part of this amazing group
#EAPCI @escardio #ACVC #associations #societies
Tonje R. Johannessen retweeted
PROPOSAL for a new clinical classification of acute myocardial infarction
Published online today @NatureMedicine
Open access link: rdcu.be/dkvtT
#ESC2023 🧵[1/10]
Tonje R. Johannessen retweeted
NEW: 2023 #ESCGuidelines for the management of #AcuteCoronarySyndromes 👉escardio.org/Guidelines/Clin…
#ACS #medtwitter #ESCCongress
Tonje R. Johannessen retweeted
📰doi.org/10.1016/j.ajem.2023.…
NSTE–#ACS: diagnostic challenge⬇️
🚨Delay in reperfusion is still problematic in NSTE–ACS OMI
Important data from @smithECGBlog @PendellM and co
May AI driven #EKG interpretation increase OMI detection rate? @RobertHermanMD
#MedTwitter #CardioTwitter
Tonje R. Johannessen retweeted
Single high-sensitivity troponin sample below the limit of detection to safely rule out NSTEMI-ACS: is this enough? Read the latest Editorial in #EHJ:
academic.oup.com/eurheartj/a…
#troponin #ruleout #MI #HighSTEACS #trial #cardiotwitter @escardio @ESC_Journals
Tonje R. Johannessen retweeted
Now available @JACCJournals: from the @IFCC_CCB Committee on Clinical Applications of Cardiac Bio-Markers (C-CB): Single Troponin Measurement to Rule Out Myocardial Infarction jacc.org/doi/10.1016/j.jacc.…
Tonje R. Johannessen retweeted
Doing a literature review takes time — a lot of time.
Here's a new workflow that will supercharge your literature review.
You can learn this workflow in 15 min.
Tonje R. Johannessen retweeted
Why doesn’t everyone love cardiac troponin?
Current challenges in practice and a solution: #CoDEACS @NatureMedicine 🧵[1/12]
nature.com/articles/s41591-0…
Tonje R. Johannessen retweeted
Gratulerer @hcmyklestul med Skribentprisen 2022! Du kan lese innlegget på #Medisinbloggen til
@UniOslo_MED
med.uio.no/om/aktuelt/blogg/…
@legeforeningen
Gratulerer med årets skribentpris fra @legeforeningen til @hcmyklestul 👏🏆 Teksten Myklestul vinner årets pris for, "Hva er greia med fastlegeordningen?", er publisert i #Medisinbloggen @UniOslo
Les innlegget: med.uio.no/om/aktuelt/blogg/…
Tonje R. Johannessen retweeted
We developed CoDE-ACS, an algorithm for suspected ACS
🟢Rules out MI in 2X more patients at presentation
🟡Reduce inequalities across subgroups
♥️Improve identification of Type 1 MI
Published today @NatureMedicine @DDoudesis @J_Boeddinghaus @HighSTEACS
nature.com/articles/s41591-0…








































